| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.098 | 0.08 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.082 | 0.08 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.051 | 0.08 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.09 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 0.09 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |